XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Treasury Stock
Warrants
Additional Paid-In- Capital
Accumulated Deficit
Non- Controlling Interest
Beginning balance (in shares) at Dec. 31, 2023   29,364          
Beginning balance at Dec. 31, 2023 $ 14,093 $ 389 $ (116,701) $ 2,219 $ 462,583 $ (333,797) $ (600)
Net (loss) income (2,673)         (2,767) 94
Shares issued under equity compensation plan (in shares)   81          
Shares issued under equity compensation plan (665) $ 3 (665)   (3)    
Proceeds from exercise of warrants (in shares)   240          
Proceeds from exercise of warrants 1,309 $ 2   (474) 1,781    
Distributions to non-controlling interest (179)           (179)
Stock-based compensation expense 1,771       1,771    
Ending balance (in shares) at Mar. 31, 2024   29,685          
Ending balance at Mar. 31, 2024 $ 13,656 $ 394 (117,366) 1,745 466,132 (336,564) (685)
Beginning balance (in shares) at Dec. 29, 2024 29,893 29,893          
Beginning balance at Dec. 29, 2024 $ 57,948 $ 398 (120,338) 1,745 470,085 (293,503) (439)
Net (loss) income 85         (62) 147
Shares issued under equity compensation plan (in shares)   114          
Shares issued under equity compensation plan (236) $ 1 (236)   (1)    
Proceeds from exercise of warrants 358 $ 1   (131) 488    
Distributions to non-controlling interest (222)           (222)
Stock-based compensation expense 1,548       1,548    
Repurchases of common stock (in shares)   (117)          
Repurchases of common stock $ (1,128)   (1,128)        
Ending balance (in shares) at Mar. 30, 2025 29,890 29,890          
Ending balance at Mar. 30, 2025 $ 58,353 $ 400 $ (121,702) $ 1,614 $ 472,120 $ (293,565) $ (514)